EAM Investors’s Novavax NVAX Stock Holding History

EAM Investors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-39,055	Closed	-$3.25M	–	331
2020 Q2	$3.25M	Buy	+39,055	New	+$1.49M	0.72%	20
2018 Q2	–	Sell	-21,552	Closed	-$905K	–	335
2018 Q1	$905K	Buy	+21,552	New	+$866K	0.15%	212
2015 Q4	–	Sell	-10,664	Closed	-$1.51M	–	348
2015 Q3	$1.51M	Sell	10,664 -9,628	-47%	-$2.16M	0.24%	204
2015 Q2	$4.52M	Sell	20,292 -6,872	-25%	-$1.21M	0.53%	45
2015 Q1	$4.49M	Sell	27,164 -7,720	-22%	-$1.25M	0.52%	32
2014 Q4	$4.14M	Buy	34,884 +12,241	+54%	+$1.28M	0.58%	22
2014 Q3	$1.89M	Sell	22,643 -2,297	-9%	-$208K	0.38%	81
2014 Q2	$2.3M	Sell	24,940 -2,733	-10%	-$240K	0.44%	48
2014 Q1	$2.51M	Sell	27,673 -2,264	-8%	-$253K	0.45%	51
2013 Q4	$3.07M	Buy	29,937 +13,997	+88%	+$989K	0.55%	34
2013 Q3	$1.01M	Buy	+15,940	New	+$898K	0.2%	265

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EAM Investors's NVAX Position: Q3 2020 in Review

EAM Investors sold out of Novavax (NVAX) in Q3 2020, closing a stake of 39,055 shares — an estimated $3.25M sold.

EAM Investors first reported a position in NVAX in Q3 2013 and held it in 11 quarters. The position peaked at $4.52M in Q2 2015. 311 funds tracked by Wall St. Rank hold NVAX as of Q3 2020.

EAM Investors reported no remaining Novavax position as of Q3 2020 after selling out during the quarter.
EAM Investors sold 39,055 Novavax shares in Q3 2020, an estimated $3.25M.
EAM Investors first reported a position in Novavax in Q3 2013 and held it in 11 quarters.
EAM Investors's Novavax position peaked at $4.52M in Q2 2015.
311 funds tracked by Wall St. Rank held Novavax as of Q3 2020.

Based on EAM Investors's 13F filing for Q3 2020, filed 13 Nov 2020.